IBDEI21X ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34392,1,3,0)
 ;;=3^Sleep Apnea,Unspec
 ;;^UTILITY(U,$J,358.3,34392,1,4,0)
 ;;=4^G47.30
 ;;^UTILITY(U,$J,358.3,34392,2)
 ;;=^5003977
 ;;^UTILITY(U,$J,358.3,34393,0)
 ;;=R20.0^^157^1747^2
 ;;^UTILITY(U,$J,358.3,34393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34393,1,3,0)
 ;;=3^Anesthesia of Skin
 ;;^UTILITY(U,$J,358.3,34393,1,4,0)
 ;;=4^R20.0
 ;;^UTILITY(U,$J,358.3,34393,2)
 ;;=^5019278
 ;;^UTILITY(U,$J,358.3,34394,0)
 ;;=F44.7^^157^1747^3
 ;;^UTILITY(U,$J,358.3,34394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34394,1,3,0)
 ;;=3^Conversion Disorder w/ Mixed Symptoms
 ;;^UTILITY(U,$J,358.3,34394,1,4,0)
 ;;=4^F44.7
 ;;^UTILITY(U,$J,358.3,34394,2)
 ;;=^5003582
 ;;^UTILITY(U,$J,358.3,34395,0)
 ;;=G91.9^^157^1747^10
 ;;^UTILITY(U,$J,358.3,34395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34395,1,3,0)
 ;;=3^Hydrocephalus,Unspec
 ;;^UTILITY(U,$J,358.3,34395,1,4,0)
 ;;=4^G91.9
 ;;^UTILITY(U,$J,358.3,34395,2)
 ;;=^5004178
 ;;^UTILITY(U,$J,358.3,34396,0)
 ;;=G98.8^^157^1747^8
 ;;^UTILITY(U,$J,358.3,34396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34396,1,3,0)
 ;;=3^Disorders of Nervous System,Other
 ;;^UTILITY(U,$J,358.3,34396,1,4,0)
 ;;=4^G98.8
 ;;^UTILITY(U,$J,358.3,34396,2)
 ;;=^5004214
 ;;^UTILITY(U,$J,358.3,34397,0)
 ;;=R53.83^^157^1747^9
 ;;^UTILITY(U,$J,358.3,34397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34397,1,3,0)
 ;;=3^Fatigue,Other
 ;;^UTILITY(U,$J,358.3,34397,1,4,0)
 ;;=4^R53.83
 ;;^UTILITY(U,$J,358.3,34397,2)
 ;;=^5019520
 ;;^UTILITY(U,$J,358.3,34398,0)
 ;;=G96.8^^157^1747^7
 ;;^UTILITY(U,$J,358.3,34398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34398,1,3,0)
 ;;=3^Disorders of CNS,Other Spec
 ;;^UTILITY(U,$J,358.3,34398,1,4,0)
 ;;=4^G96.8
 ;;^UTILITY(U,$J,358.3,34398,2)
 ;;=^5004199
 ;;^UTILITY(U,$J,358.3,34399,0)
 ;;=T50.901A^^157^1747^16
 ;;^UTILITY(U,$J,358.3,34399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34399,1,3,0)
 ;;=3^Poisoning by Drug/Meds/Bio Subst,Accidental,Init
 ;;^UTILITY(U,$J,358.3,34399,1,4,0)
 ;;=4^T50.901A
 ;;^UTILITY(U,$J,358.3,34399,2)
 ;;=^5052148
 ;;^UTILITY(U,$J,358.3,34400,0)
 ;;=G93.3^^157^1747^17
 ;;^UTILITY(U,$J,358.3,34400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34400,1,3,0)
 ;;=3^Postviral Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,34400,1,4,0)
 ;;=4^G93.3
 ;;^UTILITY(U,$J,358.3,34400,2)
 ;;=^5004181
 ;;^UTILITY(U,$J,358.3,34401,0)
 ;;=R53.1^^157^1747^20
 ;;^UTILITY(U,$J,358.3,34401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34401,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,34401,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,34401,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,34402,0)
 ;;=I48.0^^157^1748^2
 ;;^UTILITY(U,$J,358.3,34402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34402,1,3,0)
 ;;=3^Proxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,34402,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,34402,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,34403,0)
 ;;=R55.^^157^1748^3
 ;;^UTILITY(U,$J,358.3,34403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34403,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,34403,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,34403,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,34404,0)
 ;;=I48.1^^157^1748^1
 ;;^UTILITY(U,$J,358.3,34404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34404,1,3,0)
 ;;=3^Persistant Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,34404,1,4,0)
 ;;=4^I48.1
 ;;^UTILITY(U,$J,358.3,34404,2)
 ;;=^5007225
 ;;^UTILITY(U,$J,358.3,34405,0)
 ;;=G00.9^^157^1749^3
 ;;^UTILITY(U,$J,358.3,34405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34405,1,3,0)
 ;;=3^Bacterial Meningitis,Unspec
 ;;^UTILITY(U,$J,358.3,34405,1,4,0)
 ;;=4^G00.9
